Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic CardiomyopathyNCT04219826CytokineticsPhase 2Completed2023-02-28Actual
Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs PlaceboNCT04221230NMRAPhase 2Completed2022-04-08Actual
Phase 2a Study of ZW25 in Combination With Palbociclib Plus FulvestrantNCT04224272Jazz PharmaceuticalsPhase 2Completed2023-04-28Actual
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2NCT04229979Sellas Life Sciences GroupPhase 3Active not recruiting2025-12Estimated
Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis PainNCT04231318ANIKPhase 3Completed2022-05-16Actual
D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional InfectionNCT04233424PYPDPhase 3Completed2022-09-02Actual
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile InfectionNCT04247542ACXPPhase 2Completed2023-10-03Actual
Gene Therapy for Fanconi Anemia, Complementation Group ANCT04248439RCKTPhase 2Active not recruiting2026-05-05Estimated
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCCNCT04260126PDSBPhase 2Completed2025-05-14Actual
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBCNCT04262804Zai Lab (Shanghai) Co., Ltd.Phase 2Unknown2021-09-03Actual
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung CancerNCT04262856RCUSPhase 2Completed2025-07-09Actual
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)NCT04264442Fulcrum TherapeuticsPhase 2Terminated2024-11-07Actual
Dexmedetomidine in the Treatment of Agitation Associated With SchizophreniaNCT04268303BioXcel Therapeutics IncPhase 3Completed2020-05-06Actual
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)NCT04270682MIRMPhase 3Completed2023-07-13Actual
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar DisorderNCT04276883BioXcel Therapeutics IncPhase 3Completed2020-05-21Actual
Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeNCT04279314ACADPhase 3Completed2022-08-19Actual
A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)NCT04282980Zai Lab (Shanghai) Co., Ltd.Phase 2Completed2021-02-26Actual
Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque PsoriasisNCT04286607ARQTPhase 3Completed2024-01-22Actual
A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant RecipientsNCT04294472VERAPhase 2Completed2022-02-10Actual
ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeNCT04304482AVXLPhase 2, Phase 3Completed2023-06-01Actual
An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary AngioedemaNCT04307381IONSPhase 2Completed2025-01-24Actual
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)NCT04308395SLGLPhase 3Terminated2021-07-14Actual
A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal AdenomasNCT04308590Corcept TherapeuticsPhase 3Completed2024-09-19Actual
Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)NCT04313153Akebia TherapeuticsPhase 3Completed2021-11-26Actual
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004NCT04314934AVXLPhase 2, Phase 3Completed2024-06-14Actual
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure SubjectsNCT04318145PTNPhase 2Terminated2023-12-08Actual
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion SicknessNCT04327661Vanda PharmaceuticalsPhase 3Completed2023-04-01Actual
Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal AdenocarcinomaNCT04329949Corcept TherapeuticsPhase 3Terminated2021-08-23Actual
A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to <2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)NCT04336826PTC TherapeuticsPhase 2Completed2023-08-07Actual
A Study of Auxora in Patients With Severe COVID-19 PneumoniaNCT04345614CALCPhase 2Completed2021-06-28Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.